NorthWest Biotherapeutics Inc (NWBO)

[ae kusterer]

hyperopia: Last friday, a good source told me Bosch would add alot of new data 7/5.Please post today's transcript , if you have access.Thanks.

Re: None

Tuesday, July 04, 2023 11:52:52 PM

Post#
606691
of 606718
I transcribed Dr. Bosch’s ASCO presentation a while ago, but didn’t post it, because I never finished matching it to the slides. I guess I’ll post it now, so people can read it and do that if they wish. I believe it’s the same one that he’ll present for the BNOS Conference happening this week at the University of Manchester.



biosectinvestor

Member Level
Re: Poor Man - post# 606624

Tuesday, July 04, 2023 11:36:03 PM

Post#
606688
of 606720
There are no legitimate debates about the company’s solvency. As Hyperopia indicates and I agree, not only is it not worse than it was over recent years, they are literally walking toward a likely approval. There are no doubt traders who want to leave their money off to the side until approval, and buy them and they do not want to have to buy back in at a higher cost, so we will see these arguments as a means to an end. But the reality is, the solvency is not currently an issue. They operate with not a lot of cash generally though to not do a huge cash draw at any one time. But they also seem to have had ready sources who ponied up cash as they needed it. So, there is always inherent risk in any biotech and always a potential for total and complete loss. That is normal in this sector at this level. But the reality is they had a successfully competed major, landmark trial, and they have consistently, successfully completed regulatory milestones in anticipation of their application for full approval.

I think it is interesting that just after UCLA’s PR suggesting that approval could be soon… there is this sudden set of claims about insolvency and never applying, etc.

“FDA approvals may move UCLA brain cancer and Alzheimer’s treatments from bench to bedside

Glioblastoma and Alzheimer’s disease treatments advance through clinical trials.”

https://www.uclahealth.org/news/fda-approval-brain-cancer-alzheimers#:~:text=Glioblastoma%20and%20Alzheimer's%20disease%20treatments%20advance%20through%20clinical%20trials.&text=A%20personalized%20vaccine%20developed%20by,aggressive%20form%20of%20brain%20cancer.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.